Invention Grant
- Patent Title: Crystalline bromodomain inhibitors
- Patent Title (中): 结晶溴结构域抑制剂
-
Application No.: US14317029Application Date: 2014-06-27
-
Publication No.: US09321765B2Publication Date: 2016-04-26
- Inventor: Yuchuan Gong
- Applicant: AbbVie Inc.
- Applicant Address: US IL North Chicago
- Assignee: AbbVie Inc.
- Current Assignee: AbbVie Inc.
- Current Assignee Address: US IL North Chicago
- Agent Glen J. Gesicki
- Main IPC: C07D471/02
- IPC: C07D471/02 ; A61K31/44 ; C07D471/04
Abstract:
N-[4-(2,4-difluorophenoxy)-3-(6-methyl-7-oxo-6,7-dihydro-1H-pyrrolo[2,3-c]pyridin-4-yl)phenyl]ethanesulfonamide and crystalline forms thereof are suitable pharmaceutical ingredients for pharmaceutical compositions useful in the treatment of disease, for example, cancer.
Public/Granted literature
- US20150005340A1 CRYSTALLINE BROMODOMAIN INHIBITORS Public/Granted day:2015-01-01
Information query
